Delivery Order SPE2DB22D2206-SPE2DB24FJC05

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,854.85 delivery order is for the supply of 4,559,987,695 units of 20 mg Sumatriptan nasal sprays. The contract has a firm fixed price pricing type and a completion date of February 21, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,468.26 firm fixed-price delivery order is for the supply of 4,567,376,308 units of 20 mg sumatriptan nasal sprays. The contract has an ultimate completion date of February 26, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,692,724 units of Sumatriptan 20 mg nasal sprays. The $1,566.49 firm fixed-price contract was awarded on March 25, 2025 by the Defense Logistics Agency (DLA), with a period of performance ending on March 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $7,368.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sumatriptan 20 mg Nasal Sprays. It is a firm-fixed-price delivery order with a completion date of June 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,652.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,925,281 units of Sumatriptan 5 mg nasal sprays, a medication used to treat migraines. The contract has a firm fixed-price, delivery order type, with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,759,086 units of Sumatriptan 5 mg nasal sprays. The $1,413.99 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, on May 30, 2024, with a completion date of May 31, 2024. The award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $1,298.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of sumatriptan 5 mg nasal sprays, with a completion date of December 7, 2023. This award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4566407817 units of Sumatriptan 20 mg nasal sprays. The $1,328.44 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 13, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4,556,432,710 units of Sumatriptan 20 mg nasal sprays to the Defense Logistics Agency (DLA). The $1,190.65 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of March 3, 2022 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery...
This federal contract award, with a value of $2,057.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,576,146 units of Sumatriptan 20 mg nasal sprays, a medication used to treat migraine headaches. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price delivery order. The contract was not set aside for any...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJC05
    Delivery Order

This federal contract award, valued at $11,187.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,091,981 units of Sumatriptan 20 mg nasal sprays, with a completion date of July 9, 2024.

The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 10:02 AM